News | October 9, 2025

Biorasi Unveils New Website To Drive Sponsor Success With Biotech-Centric Strategies And Modular CRO Solutions

Source: Biorasi

Relaunch puts customized CRO services front and center for today's Biotech and Biopharma innovators.

AVENTURA, FL / ACCESS Newswire / October 8, 2025 / Biorasi, a leading global full-service contract research organization (CRO), has relaunched its website to reflect a bold new direction: Empowering biotech sponsors with modular clinical trial solutions, AI-powered tools, and a renewed focus on sponsor-centric strategy.

"The future of clinical research belongs to those who can adapt, innovate, and deliver," said Chris O'Brien, CEO of Biorasi. "Our new website reflects a strategic evolution - one that puts biotech sponsors at the center of smarter, faster, and more flexible trials. It's a touchstone for the modular solutions and AI-powered tools that will define the next era of clinical success."

Key updates to the website include:

  • Focused Study Solutions: Critical standalone service offerings deliver the same high-performance features found in Biorasi's full-service strategies:

    • Study Rescue and Recovery Packages: Designed to salvage struggling clinical trials and restore timelines.

    • Flexible Data Sciences Solutions: Advanced analytics and biostatistics available as standalone services.

    • Specialized Services: Including Quality Assurance, Clinical Monitoring, and Safety & Pharmacovigilance, tailored to sponsor needs.

    • Accelerated Startup Modules: Fast-track solutions for trials requiring rapid market entry.

  • AI-Powered Feasibility: Dynamic clinical site modeling combined with targeted feasibility outreach and enrollment forecasting.

  • New Sponsor Strategy: A sharpened focus on the CRO competencies that matter most: Reliability, Flexibility, and Accessibility.

The redesigned website celebrates Biorasi's over two decades of industry leadership, clinical trial experience, and operational excellence:

  • Over 200 global studies executed.

  • Five FDA approvals in the past seven years.

  • $150M+ in recovered rescue studies.

  • 6 weeks or less for database go-live.

  • Kickoff Meetings in 10 business days after LOI/WO.

  • 60% repeat business from returning sponsors.

  • Studies conducted in 48 countries, reaching 65% of the global population.

Source: Biorasi